Vabysmo 120 mg/mL solution for injection in pre-filled syringe
*Company:
Roche Registration GmbHStatus:
UpdatedLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company
File name
C_CLEANED_ faricimab Additional Risk Minimization Measures Patient Guide Vabysmo Patient Guide v3.1 audio script Final Clean_V2 (2).mp3
Reasons for updating
- Add New Audio
File name
Vabysmo Patient Carer Guide IE Version 5.1.4.pdf
Reasons for updating
- Add New Doc
Updated on 14 January 2025
File name
VAB_II11_SmPC_common_19Dec2024.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 14 January 2025
File name
VAB_II11_PIL_PFS_19Dec2024.pdf
Reasons for updating
- New PIL for new product
Roche Registration GmbH
Address:
3004 Lake Drive, Citywest, Naas Road, Dublin 24Medical Information E-mail:
ireland.druginfo@roche.comTelephone:
+353 1 469 0700Fax:
+353 1 469 0791